Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of rituximab biosimialr, CT-P10, after a single switch from innovator rituximab in patients with rheumatoid arthritis: results from phase 3 randomised controlled trial over 72 weeks
- Authors
- 유대현
- Issue Date
- 7-Nov-2017
- Place
- San diego, USA
- Conference Name
- ACR 2017
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.